It has been clear for several or more months now that the Company is betting on getting the topical cream to market asap in order to fund the cost of future research and development. If the cream is substantially delayed there will be a cash crunch; they are required to disclose this in their forward looking statements.

Normal start up stuff but nevertheless, a real, yet manageable, issue..